Kakkis Emil D
- SEC CIK
- 0001248093
In the past year, 1 open-market sale filing worth $1.24M and no purchases.
Current role at each company
- RARE Ultragenyx Pharmaceutical Inc.President & CEOas of Apr 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.24M
- 1 filing
- Net
- −$1.24M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kakkis Emil D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Kakkis Emil DPresident & CEO | SSale | −54.4K | $22.80 | −$1.24M | −7.6%659.0K after | |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Kakkis Emil DPresident & CEO | SSale | −73.4K | $42.10 | −$3.09M | −10.3%641.7K after | 10b5-1 |
| Mar 4, 2025 (view filing) | Feb 28 | 4 days | Kakkis Emil DPresident & CEO | SSale | −25.0K | $42.48 | −$1.06M | −1.1%2.16M after | 10b5-1 |
| Dec 31, 2024 (view filing) | Dec 30 | 1 day | Kakkis Emil DPresident & CEO | SSale | −11.7K | $42.23 | −$495.2K | −0.5%2.18M after | 10b5-1 |
| Dec 11, 2024 (view filing) | Dec 10 | 1 day | Kakkis Emil DPresident & CEO | SSale | −8.27K | $50.00 | −$413.6K | −0.4%2.20M after | 10b5-1 |
| Sep 5, 2024 (view filing) | Sep 3 | 2 days | Kakkis Emil DPresident & CEO | SSale | −20.0K | $55.85 | −$1.12M | −0.9%2.22M after | 10b5-1 |
| Aug 7, 2024 (view filing) | Aug 6 | 1 day | Kakkis Emil DPresident & CEO | SSale | −20.0K | $50.17 | −$1.00M | −0.9%2.24M after | 10b5-1 |
| Feb 8, 2024 (view filing) | Feb 7 | 1 day | Kakkis Emil DPresident & CEO | SSale | −30.0K | $45.00 | −$1.35M | −5.3%539.8K after | |
| Jan 2, 2024 (view filing) | Dec 29, 2023 | 4 days | Kakkis Emil DPresident & CEO | SSale | −30.0K | $47.87 | −$1.44M | −5.0%569.8K after | |
| Oct 23, 2023 (view filing) | Oct 19 | 4 days | Kakkis Emil DPresident & CEO | SSale | −47.9K | $33.52 | −$1.60M | −7.4%599.7K after | |
| Jan 3, 2023 (view filing) | Dec 30, 2022 | 4 days | Kakkis Emil DPresident & CEO | SSale | −19.6K | $45.57 | −$892.4K | −3.5%541.1K after |